Cholecystokinin peptides in cerebrospinal fluid: A study in healthy male subjects

Regulatory Peptides

Volumn 68, Issue 1, 1997, Pages 57-61

  Gunnarsson, Tove ^a   Eklundh, Thomas ^a   Eriksson, Mats ^b   Ali Qureshi, G ^a   Sjöberg, Stefan ^b   Nordin, Conny ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atmospheric pressure; CCK 4; CCK 8S; Storage time; Tapping time

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; TETRAGASTRIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; HUMANS; MALE; MIDDLE AGED; PEPTIDES; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; TETRAGASTRIN;

EID: 0031568247     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)02104-0     Document Type: Article

References (30)

1. Albus M., Cholecystokinin, Prog. Neuropsychopharmacol. Biol. Psychiatry, 12 (1988) S5-S21.
2. Pittaway K.M. and Hill R.G., Cholecystokinin and pain, Pain Headache, 9 (1987) 213-246.
3. Bednar I., Forsberg G., Lindén A., Qureshi G.A. and Södersten P., Involvement of dopamine in inhibition of food intake by cholecystokinin octapeptide in male rats, J. Neuroendocrinol., 3 (1991) 491-496.
4. Bradwejn J. and Koszycki D., The cholecystokinin hypothesis of anxiety and panic disorder. In: J.R. Reeve Jr, V. Eysseleiti, T.E. Solomon and V.L.W. Go (Eds.), Cholecystokinin, The New York Academy of Sciences, New York, 1994, pp. 273-282.
5. Bradwejn J., Koszycki D. and Shriqui C., Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder, Arch. Gen. Psychiatry, 48 (1991) 603-610.
6. Le Melledo J.-M., Bradwejn J., Koscycki, D. and Bichet, D., Premenstrual dysphoric disorder and response to cholecystokinin tetrapeptide, Arch. Gen. Psychiatry, 52 (1995) 605-606.
7. de Montigny C., Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers, Arch. Gen. Psychiatry, 46 (1989) 511-517.
8. Bradwejn J., Koszycki D., Couëtoux du Tertre A., van Megen H., den Boer J., Westenberg H. and Annable L., The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L365 260, a central cholecystokinin receptor antagonist, in patients with panic disorder, Arch. Gen. Psychiatry, 51 (1994) 486-493.
9. Bradwejn J., Koszycki D., Paradis M., Reece P., Hinton J. and Sedman A., Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers, Biol. Psychiatry, 38 (1995) 742-746.
10. Rehfeld J.F. and Kruse-Larsen C., Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity, Brain Res., 155 (1978) 19-26.
11. Beinfeld M.C. and Garver D.L., Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response, Prog. Neuro-Psychpopharmacol. Biol. Psychiatry, 15 (1991) 601-609.
12. Lydiard R.B., Ballenger J.C., Laraia M.T., Fossey M.D. and Beinfeld M.C., CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects, Am. J. Psychiatry, 149 (1992) 691-693.
13. Lydiard R.B., Brewerton T.D., Fossey M.D., Laraia M.T., Stuart G., Beinfeld M.C. and Ballenger J.G., CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects, Am. J. Psychiatry, 150 (1993) 1099-1101.
14. Bertilsson L. and Åsberg M., Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects. In: E. Usdin, M. Åsberg, L. Bertilsson and F. Sjöqvist (Eds.), Frontiers in Biochemical and Pharmacological Research in Depression, Raven Press, New York, 1984, pp. 27-34.
15. Nordin C., Swedin A. and Zachau A., Tapping-time influences concentrations of 5-HIAA in the CSF, J. Psychiatr. Res., 27 (1993) 409-414.
16. Eklundh T., Fernström V. and Nordin C., Influence of tapping-time and atmospheric pressure on concentrations of monoamine metabolites in the cerebrospinal fluid - a prospective study in female volunteers, J. Psychiatr. Res., 28 (1994) 511-517.
17. Nordin C., Eklundh T., Fernström V., Swedin A. and Zachau A.C., Gradients of CSF monoamine metabolites: A comparison between male and female volunteers. J. Psychiatr. Res., 29 (1995) 133-140.
18. Nordin C., Lindström L. and Wieselgren I.-M., Acid monoamine metabolites in the CSF of healthy controls: A retrospective study, J. Psychiatr. Res., 30 (1996) 127-133.
19. Löfberg C., Harro J., Gottfries C-G. and Oreland L. Cholecystokinin peptides and receptor binding in Alzheimer's disease, J. Neural Transm., 103 (1996) 851-860.
20. Sauter A. and Frick W., Determination of cholecystokinin tetrapeptide and cholecystokinin octapeptide sulfate in different rat brain regions by high-pressure liquid chromatography with electrochemical detection, Anal. Biochem., 133 (1983) 307-313.
21. Marley P.D., Rehfeld J.F. and Emson P.C., Distribution and chromatographic characterisation of gastrin and cholecystokinin in the rat central nervous system, J. Neurochem., 42 (1984) 1523-1535.
22. Qureshi G.A., Bednar I., Min Q., Södersten P., Silberring J., Nyberg F. and Thörnwall M., Quantitation and identification of two cholecystokinin peptides, CCK-4 and CCK-8S, in rat brain by HPLC and fast atom bombardment mass spectrometry, Biomed. Chromatogr., 7 (1993) 251-255.
23. Eklundh T., Eriksson M., Sjöberg S. and Nordin C., Monoamine precursors, transmitters and metabolites in cerebrospinal fluid. A prospective study in healthy male subjects, J. Psychiatr. Res., 30 (1996) 201-208.
24. Kleinbaum D.G., Kupper L.L. and Muller K.E., Applied Regression Analyses and Other Multivariable Methods, PWS-KENT Publishing Company, Boston, 1988.
25. Siegel S. and Castellan Jr. N.J., Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill International editions, New York, 1988.
26. Rehfeld J.F. and Hansen H.F., Characterization of preprocholecystokinin products in the porcine cerebral cortex, J. Biol. Chem., 261 (1986) 5832-5840.
27. Pavlasevic S., Bednar I., Qureshi G.A. and Södersten P., Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety, NeuroReport, 5 (1993) 225-228.
28. Milhorat T. and Hammock M., Cerebrospinal fluid as reflection of internal milieu of brain. In: J. Wood (Ed.), Neurobiology of Cerebrospinal Fluid, Plenum Press, New York and London, 1983, pp. 1-24.
29. Magnaes B., Movement of cerebrospinal fluid within the craniospinal space when sitting up and lying down, Surg. Neurol., 10 (1978) 45-49.
30. Geracioti T.D., Nicholson W.E., Orth D.N., Ekhator N.N. and Loosen P.T. CSF cholecystokinin dynamics in the human. Abstract nr 505, Annual Meeting of the American Psychiatric Association, Miami, Florida, May 1995, p. 190.